Mayo study seeks to pretreat Alzheimer's in effort to prevent brain damage

by Stacey Burling

The day is coming when doctors will be able to diagnose and treat Alzheimer's disease before people have symptoms, and Ronald Petersen is among the doctors laying the groundwork for that future.

Petersen is director of the Mayo Clinic Alzheimer's Disease Research Center, which is using detailed tests to monitor in from Olmsted County, Minn., as they age.

He discussed the early results of the study recently at a talk sponsored by several programs at the University of Pennsylvania, including the Penn Memory Center.

Among some puzzling findings, the Mayo doctors have learned that a fair number of patients look cognitively impaired one year and fine the next. They're still at higher risk for dementia than people who have never shown mild cognitive impairment, a stage that often precedes Alzheimer's.

More surprising, a high percentage of people with mild cognitive impairment had evidence of structural degeneration in their brains but not of abnormal deposits of amyloid, a hallmark found in Alzheimer's disease.

This is important, Petersen said, because drug firms are trying to develop drugs that target amyloid. So far, they haven't proven effective. It's important, he said, that such drugs be tested in the right people.

The Mayo study, which includes 4,000 people, began in 2004 with participants above age 70 who did not have dementia. In 2011, the minimum enrollment age was dropped to 50.

Scientists believe that the "preclinical" phase of Alzheimer's - the period when errant proteins are accumulating and the brain is changing but there are no symptoms - may last 15 years. The goal is to diagnose and treat people before their brains are irreparably damaged.

Doctors can't do that yet, but researchers are studying how and tests of spinal fluid correlate with changes in thinking and memory.

An earlier study of the Mayo group found that about 16 percent of those ages 70 to 89 had .

Petersen said that about half of patients without physical evidence of disease tested normal a year later while 8 percent progressed to dementia. Seventeen percent of patients who had signs of amyloid deposition and structural changes progressed to a dementia diagnosis in a year while only 5 percent returned to normal. Meanwhile, the patients who had apparent neurodegeneration progressed at the highest rate - 22 percent - and also returned to normal at the highest rate - 36 percent. "There's a lot of bounce here," Petersen said.

Petersen foresees a time when a diagnosis will be more complicated than it is now. It will include information on which proteins have gone awry, genetics, and other medical problems. All of that will allow for more targeted treatments and it may mean that people who are now said to have Alzheimer's disease will get a different diagnosis.

Meanwhile Mayo doesn't tell study participants what all of its tests are finding, although it will share tests with their if patients want it. "It's research information," he said. "We don't know what it means."

not rated yet
add to favorites email to friend print save as pdf

Related Stories

No link between anesthesia, dementia in elderly

May 01, 2013

Elderly patients who receive anesthesia are no more likely to develop long-term dementia or Alzheimer's disease than other seniors, according to new Mayo Clinic research. The study analyzed thousands of patients using the ...

Study finds mild cognitive impairment is more common in men

Sep 06, 2010

A new Mayo Clinic study found that the prevalence of mild cognitive impairment was 1.5 times higher in men than in women. The research, part of the Mayo Clinic Study of Aging, also showed a prevalence rate of 16 percent in ...

Cardiac disease linked to higher risk of mental impairment

Jan 28, 2013

Cardiac disease is associated with increased risk of mild cognitive impairment such as problems with language, thinking and judgment—particularly among women with heart disease, a Mayo Clinic study shows. Known as nonamnestic ...

Gene is marker only for mild cognitive impairment

Feb 12, 2013

Defying the widely held belief that a specific gene is the biggest risk factor for Alzheimer's disease, two Cornell developmental psychologists and their colleagues report that people with that gene are more ...

Recommended for you

Cold sores increase the risk of dementia

10 hours ago

Infection with herpes simplex virus increases the risk of Alzheimer's disease. Researchers at Umeå University, Sweden, claim this in two studies in the journal Alzheimer's & Dementia.

World first effort to prevent dementia in high-risk people

Oct 15, 2014

Dementia will soon engulf more than 100 million people across the globe, but an international research group is leading a world-first effort to prevent dementia in people who are at high risk of this insidious disease.

Aluminium and its likely contribution to Alzheimer's disease

Oct 13, 2014

A world authority on the link between human exposure to aluminium in everyday life and its likely contribution to Alzheimer's disease, Professor Christopher Exley of Keele University, UK, says in a new report that it may ...

User comments